Coloplast A/S (CLPBY)
OTCMKTS · Delayed Price · Currency is USD
7.54
-0.05 (-0.66%)
At close: Nov 9, 2026
Coloplast Revenue
In the fiscal year ending September 30, 2026, Coloplast had annual revenue of 28.94B DKK with 3.83% growth. Coloplast had revenue of 7.46B in the quarter ending September 30, 2026, with 7.17% growth.
Revenue
28.94B DKK
Revenue Growth
+3.83%
P/S Ratio
3.81
Revenue / Employee
1.68M DKK
Employees
17,270
Market Cap
16.76B USD
Revenue by Segment
Fiscal year ended Sep 30, 2026 See the full Coloplast breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2026 | 28.94B | 1.07B | 3.83% |
| Sep 30, 2025 | 27.87B | 844.00M | 3.12% |
| Sep 30, 2024 | 27.03B | 2.53B | 10.33% |
| Sep 30, 2023 | 24.50B | 1.92B | 8.51% |
| Sep 30, 2022 | 22.58B | 3.15B | 16.23% |
| Sep 30, 2021 | 19.43B | 882.00M | 4.76% |
| Sep 30, 2020 | 18.54B | 605.00M | 3.37% |
| Sep 30, 2019 | 17.94B | 1.49B | 9.06% |
| Sep 30, 2018 | 16.45B | 921.00M | 5.93% |
| Sep 30, 2017 | 15.53B | 847.00M | 5.77% |
| Sep 30, 2016 | 14.68B | 772.00M | 5.55% |
| Sep 30, 2015 | 13.91B | 1.48B | 11.92% |
| Sep 30, 2014 | 12.43B | 793.00M | 6.82% |
| Sep 30, 2013 | 11.64B | 612.00M | 5.55% |
| Sep 30, 2012 | 11.02B | 851.00M | 8.37% |
| Sep 30, 2011 | 10.17B | 635.00M | 6.66% |
| Sep 30, 2010 | 9.54B | 717.00M | 8.13% |
| Sep 30, 2009 | 8.82B | 357.00M | 4.22% |
| Sep 30, 2008 | 8.46B | 421.00M | 5.24% |
| Sep 30, 2007 | 8.04B | 1.33B | 19.87% |
| Sep 30, 2006 | 6.71B | 477.00M | 7.65% |
| Sep 30, 2005 | 6.23B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Meihua International Medical Technologies | 61.79M |
| InnerScope Hearing Technologies | 14.51M |
| Encision | 6.30M |
| Lancer Orthodontics | 6.19M |
| Reflect Scientific | 1.72M |
| Standard Dental Labs | 415.61K |
| Hear AtLast Holdings | 93.20K |
| Cardiac Biotech Solutions | 50.37K |
Coloplast News
- 6 days ago - Coloplast pares back China operations as market recovery remains elusive - Reuters
- 6 days ago - Coloplast Transcript: Q4 25/26 - Transcripts
- 6 days ago - Coloplast Quarterly report: Q4 2026 - Filings
- 6 days ago - Coloplast Annual report: Q4 2026 - Filings
- 6 days ago - Coloplast Slides: Q4 2026 - Filings
- 6 days ago - Coloplast Slides: Investor presentation - Filings
- 2 months ago - Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says - Reuters
- 2 months ago - Coloplast Transcript: Q3 25/26 - Transcripts